Financials
- Market Capitalization 11.99 B
- Employee 711
- Founded 2004
- CEO Christopher Richard Anzalone
- Website www.arrowheadpharma.com
- Headquarter Delaware, United States
- FIGI BBG000BRVKH0
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-37.39
Fiyat/satışlar oranı
16.85
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 809 | MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 533.76 USD | -1.83% | +3.24% | +15.49% | +26.00% | 12.33 B USD | ||
| 810 | CORT Corcept Therapeutics Incorporated - Common Stock | 113.88 USD | -2.61% | -5.54% | -0.25% | +55.21% | 12.31 B USD | ||
| 826 | HALO Halozyme Therapeutics, Inc. - Common Stock | 105.35 USD | -1.47% | -2.53% | +27.54% | +57.71% | 11.96 B USD | ||
| 852 | TECH Bio-Techne Corp - Common Stock | 72.35 USD | -0.17% | +0.11% | +0.29% | +33.56% | 11.35 B USD |